Skandinaviska Enskilda Banken (SEB)’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-98,300
| Closed | -$1.12M | – | 868 |
|
|
2023
Q4 | $1.12M | Sell |
98,300
-51,600
| -34% | -$590K | 0.01% | 682 |
|
|
2023
Q3 | $1.44M | Sell |
149,900
-70,900
| -32% | -$683K | 0.01% | 613 |
|
|
2023
Q2 | $2.35M | Buy |
220,800
+158,200
| +253% | +$1.68M | 0.02% | 527 |
|
|
2023
Q1 | $659K | Buy |
+62,600
| New | +$659K | ﹤0.01% | 743 |
|
|
2022
Q3 | – | Sell |
-135,500
| Closed | -$1.56M | – | 970 |
|
|
2022
Q2 | $1.56M | Sell |
135,500
-107,300
| -44% | -$1.24M | 0.01% | 632 |
|
|
2022
Q1 | $3.05M | Sell |
242,800
-171,700
| -41% | -$2.16M | 0.02% | 520 |
|
|
2021
Q4 | $4.85M | Sell |
414,500
-1,805,900
| -81% | -$21.1M | 0.03% | 429 |
|
|
2021
Q3 | $29M | Buy |
2,220,400
+2,005,800
| +935% | +$26.2M | 0.16% | 140 |
|
|
2021
Q2 | $2.76M | Sell |
214,600
-1,000
| -0.5% | -$12.9K | 0.02% | 580 |
|
|
2021
Q1 | $2.41M | Sell |
215,600
-467,300
| -68% | -$5.22M | 0.02% | 605 |
|
|
2020
Q4 | $7.78M | Buy |
682,900
+281,300
| +70% | +$3.2M | 0.05% | 291 |
|
|
2020
Q3 | $3.61M | Buy |
401,600
+192,400
| +92% | +$1.73M | 0.03% | 407 |
|
|
2020
Q2 | $2.16M | Buy |
209,200
+167,300
| +399% | +$1.73M | 0.02% | 532 |
|
|
2020
Q1 | $423K | Sell |
41,900
-144,300
| -77% | -$1.46M | ﹤0.01% | 762 |
|
|
2019
Q4 | $2.48M | Buy |
+186,200
| New | +$2.48M | 0.02% | 500 |
|
|
2019
Q1 | – | Sell |
-276,292
| Closed | -$2.4M | – | 723 |
|
|
2018
Q4 | $2.4M | Buy |
+276,292
| New | +$2.4M | 0.02% | 427 |
|